Professor Franklin Aigbirhio is a Senior Research Fellow at Magdalene.
My research is in the development and application of biomedical imaging methods, in particular for the imaging technique of positron emission tomography. My objectives are to design and apply new imaging probes that are specific to human biological markers and are sensitive to in vivo biochemical changes associated with different diseases, such as dementias and cancers. Thereby enable clinical imaging to be applied to investigate disease mechanisms, their early detection and diagnosis and develop new treatments.
BSc (Hons), MA (Cantab), DPhil (Sussex), CChem FRSC.
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT.
Ageing Res Rev. 2017 Jul;36:50-63.
DOI: 10.1016/j.arr.2017.03.002. PubMed PMID: 28315409.
Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, Gurnell M, Gilbert FJ.
Diagnostics (Basel). 2016 Nov 18;6(4). pii: E42.
PubMed PMID: 27869719.
Positron emission tomography radiopharmaceutical studies in humans: a guide to regulations for academic researchers
Fleming IN, Whelan M, Baxendale R, Gilbert FJ, Matthews PP, Aigbirhio FI.
Nucl Med Commun. 2012 Sep;33(9):899-906.
DOI: 10.1097/MNM.0b013e328356737f.. PubMed PMID: 22773151.